Kenneth Grossmann

Kenneth Grossmann

UNVERIFIED PROFILE

Are you Kenneth Grossmann?   Register this Author

Register author
Kenneth Grossmann

Kenneth Grossmann

Publications by authors named "Kenneth Grossmann"

Are you Kenneth Grossmann?   Register this Author

36Publications

1433Reads

21Profile Views

Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.

Acta Oncol 2020 Jan 10:1-4. Epub 2020 Jan 10.

Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2020.1712473DOI Listing
January 2020

Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).

J Am Acad Dermatol 2018 Aug 1;79(2):238-244. Epub 2018 Mar 1.

Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2018.02.055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754624PMC
August 2018

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

J Clin Oncol 2018 02 3;36(4):383-390. Epub 2017 Jul 3.

James Larkin, Royal Marsden NHS Foundation Trust, London; Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom; David Minor, California Pacific Medical Center Research Institute; Adil Daud, University of California San Francisco, San Francisco; Bartosz Chmielowski, University of California, Santa Monica, CA; Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Jeffrey Weber, Perlmutter Cancer Center at New York University-Langone Medical Center, New York; Nikhil Khushalani, Roswell Park Cancer Institute, Buffalo, NY; Gerald Linette, Washington University, St. Louis, MO; Christopher D. Lao, University of Michigan, Ann Arbor, MI; Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT; Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Jeffrey Sosman, Northwestern University, Chicago, IL; Dana Walker, George Kong, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ; Bart Neyns, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium; Michael Smylie, Cross Cancer Institute, Edmonton, Alberta; Wilson H. Miller Jr, Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, Quebc, Canada; Ralf Gutzmer, Medizinische Hochschule Hannover, Hannover; Jessica C. Hassel, Nationale Centrum für Tumorerkrankungen Heidelberg, Heidelberg; Dirk Schadendorf, University Hospital Essen, Essen, Germany; and Christoph Hoeller, Medical University of Vienna, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.8023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804912PMC
February 2018

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials.

J Clin Oncol 2017 Dec 25;35(34):3807-3814. Epub 2017 Aug 25.

Dirk Schadendorf, University Hospital Essen and the German Cancer Consortium, Essen, Germany; Jedd D. Wolchok and Michael A. Postow, Memorial Sloan Kettering Cancer Center; Michael A. Postow, Weill Cornell Medical College, New York, NY; F. Stephen Hodi, Dana-Farber Cancer Institute; David McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Vanna Chiarion-Sileni, Istituto Oncologico Veneto, Veneto, Italy; Rene Gonzalez, University of Colorado Denver, Aurora, CO; Piotr Rutkowski, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jean-Jacques Grob, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille Timone, Marseille; Caroline Robert, Gustave Roussy and Université Paris-Sud, Paris, France; C. Lance Cowey, Texas Oncology-Baylor Cancer Center, Dallas, TX; Christopher D. Lao, University of Michigan, Ann Arbor, MI; Jason Chesney, University of Louisville, Louisville, KY; Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT; Dana Walker and Rafia Bhore, Bristol-Myers Squibb, Princeton, NJ; and James Larkin, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.2289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791828PMC
December 2017

Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.

Head Neck 2017 05 25;39(5):876-880. Epub 2017 Feb 25.

Division of Otolaryngology - Head and Neck Surgery, The University of Utah School of Medicine, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24679DOI Listing
May 2017

Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).

Int J Radiat Oncol Biol Phys 2016 06;95(2):632-46

Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://ocpe.mcw.edu/sites/ocpe.mcw.edu/files/users/561/Avoid
Web Search
http://dx.doi.org/10.1016/j.ijrobp.2016.01.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102246PMC
June 2016

Detection of Exosomal miRNAs in the Plasma of Melanoma Patients.

J Clin Med 2015 Dec 17;4(12):2012-27. Epub 2015 Dec 17.

Department of Pathology and Laboratory Medicine, Center for Cancer Research, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN 38163, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm4121957DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693157PMC
December 2015

Adjuvant treatment for patients with surgically resected advanced-stage melanoma.

Clin Adv Hematol Oncol 2015 Oct;13(10):633-5

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
October 2015

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

N Engl J Med 2015 Jul 31;373(1):23-34. Epub 2015 May 31.

From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698905PMC
July 2015

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.

N Engl J Med 2015 May 20;372(21):2006-17. Epub 2015 Apr 20.

From Memorial Sloan Kettering Cancer Center (M.A.P., J.D.W.), Weill Cornell Medical College (M.A.P., J.D.W.), and New York University, Perlmutter Cancer Center (A.C.P.) - all in New York; J. Graham Brown Cancer Center, University of Louisville, Louisville, KY (J.C.); Institute Gustave Roussy, Villejuif (C.R.), Paris-Sud University, Orsay (C.R.), and Institut Universitaire du Cancer, Toulouse (N.M.) - all in France; Huntsman Cancer Institute, Salt Lake City (K.G.); Beth Israel Deaconess Medical Center (D. McDermott) and Dana-Farber Cancer Institute (P.A.O., F.S.H.) - both in Boston; Washington University in St. Louis, St. Louis (G.P.L.); Greenville Health System, Greenville, SC (J.K.G.); St. Luke's Cancer Center, Bethlehem, PA (S.S.A.); University of New Mexico, Albuquerque (M.S.); Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland (M.S.E.); California Pacific Center for Melanoma Research, San Francisco (D. Minor); Duke University, Durham, NC (A.K.S.); Oregon Health and Science University, Portland (M.T.); Bristol-Myers Squibb, Lawrenceville, NJ (C.H.); and Bristol-Myers Squibb, Wallingford, CT (L.M.R., P.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1414428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744258PMC
May 2015

Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications.

Ther Adv Med Oncol 2015 May;7(3):181-91

Division of Oncology, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834015572284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406913PMC
May 2015

Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ.

J Am Acad Dermatol 2014 Oct;71(4):835-8

Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah; Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.06.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167347PMC
October 2014

Sustained remission of Parkinson disease associated melanoma with immunotherapy.

Parkinsonism Relat Disord 2014 Sep 13;20(9):1027-9. Epub 2014 Jun 13.

Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2014.05.017DOI Listing
September 2014

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.

Target Oncol 2014 Mar 23;9(1):63-71. Epub 2013 Apr 23.

Department of Pharmacy Services, University of Washington Medical Center/Seattle Cancer Care Alliance, 825 Eastlake Ave. East, Seattle, WA, 98109, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-013-0276-7DOI Listing
March 2014

Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma.

J Clin Oncol 2013 Jun 6;31(17):e283-7. Epub 2013 May 6.

Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.7755DOI Listing
June 2013

Sentinel lymph node biopsy for melanoma in pregnant women.

Ann Surg Oncol 2013 Feb 6;20(2):689-96. Epub 2012 Oct 6.

Melanoma and Cutaneous Oncology Program, Huntsman Cancer Institute, University of Utah and Intermountain Health Care, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-012-2633-7
Publisher Site
http://dx.doi.org/10.1245/s10434-012-2633-7DOI Listing
February 2013

Molecular testing in malignant melanoma.

Diagn Cytopathol 2012 Jun;40(6):503-10

Department of Pathology, ARUP Laboratories, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22810DOI Listing
June 2012